Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Sheitman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Psychiatric Research|October 30, 1998
The natural history and pathophysiology of treatment resistant schizophreniaB B Sheitman, J A Lieberman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticityJ A Lieberman, B B Sheitman, B J Kinon
Brain Research. Brain Research Reviews|April 21, 1999
An integrated view of pathophysiological models of schizophreniaG E Duncan, B B Sheitman, J A Lieberman
The American Journal of Psychiatry|November 14, 1997
High-dose olanzapine for treatment-refractory schizophreniaB B Sheitman, J C Lindgren, J Early, et al.
The American Journal of Psychiatry|September 15, 1999
Olanzapine-induced elevation of plasma triglyceride levelsB B Sheitman, P M Bird, W Binz, et al.
Schizophrenia Bulletin|January 1, 1997
The evaluation and treatment of first-episode psychosisB B Sheitman, H Lee, R Strous, et al.
The American Journal of Psychiatry|June 1, 1996
Tardive dyskinesia induced by risperidone?M G Woerner, B B Sheitman, J A Lieberman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 18, 1997
Adverse effects of clomipramineJ R Brasić, J Y Barnett, B B Sheitman, et al.
Psychological Reports|January 29, 1999
Clinical assessment of adventitious movementsJ R Brasić, J Y Barnett, B B Sheitman, et al.
Schizophrenia Research|December 20, 2000
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman, M G Murray, J A Snyder, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Psychiatric Research|October 30, 1998
The natural history and pathophysiology of treatment resistant schizophreniaB B Sheitman, J A Lieberman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticityJ A Lieberman, B B Sheitman, B J Kinon
Brain Research. Brain Research Reviews|April 21, 1999
An integrated view of pathophysiological models of schizophreniaG E Duncan, B B Sheitman, J A Lieberman
The American Journal of Psychiatry|November 14, 1997
High-dose olanzapine for treatment-refractory schizophreniaB B Sheitman, J C Lindgren, J Early, et al.
The American Journal of Psychiatry|September 15, 1999
Olanzapine-induced elevation of plasma triglyceride levelsB B Sheitman, P M Bird, W Binz, et al.
Schizophrenia Bulletin|January 1, 1997
The evaluation and treatment of first-episode psychosisB B Sheitman, H Lee, R Strous, et al.
The American Journal of Psychiatry|June 1, 1996
Tardive dyskinesia induced by risperidone?M G Woerner, B B Sheitman, J A Lieberman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 18, 1997
Adverse effects of clomipramineJ R Brasić, J Y Barnett, B B Sheitman, et al.
Psychological Reports|January 29, 1999
Clinical assessment of adventitious movementsJ R Brasić, J Y Barnett, B B Sheitman, et al.
Schizophrenia Research|December 20, 2000
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman, M G Murray, J A Snyder, et al.
Pageof 2